ClinicalTrials.gg
CompletedNCT01226433Updated Mar 29, 2013

Family Planning Through Dairy Cooperatives

An observational study in The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through and Land O' Lakes-supported Dairy Cooperatives, sponsored by FHI 360. Completed at 1 site in Kenya. Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-03-29.

Primary conditionAcquired Immunodeficiency Syndrome(the registry's first term)UnverifiedIs this wrong?The registry often attaches Acquired Immunodeficiency Syndrome to studies about something else, and this study's title and listed conditions do not name it. No better condition is named, so the registry's term is kept.

Sponsored by FHI 360 · Observational

Study type
Observational
Enrollment
319
Ages
18 Years to 49 Years
Sex
Female
01

Study summary

This observational study will assess a model for providing family planning through quarterly events organized by dairy cooperatives supported by Land O'Lakes in Kenya.

Read the detailed description

Access to family planning and other reproductive health services remains difficult in much of rural Kenya. One option for improving rural access to family planning is to use existing community events outside of the health sector as platforms for delivering information and services. This study will assess a model for providing family planning through quarterly events organized by dairy cooperatives supported by Land O'Lakes in Kenya. During these events, known as Field Days, a healthcare provider will have a tent in which Field Day attendees can receive basic family health services free of charge. The services offered will be: family planning counseling and methods, immunizations, antenatal care, screening and treatment for sexually transmitted infections, and HIV counseling and testing. Since the services are no different than those that could be obtained at Ministry of Health or some private facilities, the service provision is not considered to be part of the research.

Women receiving any service from the health care provider will be recruited for an interview that will measure their demand for family planning and attitudes about receiving services during the field day. In addition, the study will track the number of different types of services provided, the total number of Field Day attendees, and the cost of the service model. The study will be carried out at five Field Days in Rift Valley and Central provinces.

Participants will not be tested for STI/HIV as part of this research; however, at their request, they may have received a test from the provider prior to the research interview. At the time of consent, they will have already received the test, so the consent form will not include anything specific to testing. In Kenya, all STI/HIV test results are reported to the national public health authorities. These reports are not used for contacting patients but for planning purposes.

02

Conditions studied

  • The Study Goal is to Assess the Introduction of Sustainable Family Planning/Reproductive Health Information and Services Through
  • Land O' Lakes-supported Dairy Cooperatives

Browse trials for

Keywords

  • AE adverse event
  • AIDS acquired immunodeficiency syndrome
  • ALT (SGPT) alanine aminotransferase
  • ART antiretroviral therapy
  • AST (SGOT) aspartate aminotransferase
  • DCF data collection forms
  • DMC Data Monitoring Committee
  • FDA (U.S.) Food and Drug Administration
  • GCP Good Clinical Practice guidelines
  • HB sAg Hepatitis B surface antigen
  • ICH International Conference of Harmonisation
  • IND Investigational New Drug Application
  • IRB Institutional Review Board
  • IU International units
  • mg milligram(s)
  • mm3 cubic millimeter(s)
  • PCR polymerase chain reaction
  • SAE serious adverse event
  • µg microgram
  • ULN upper limit of the normal range
  • WB Western Blot
03

In context

Acquired Immunodeficiency Syndrome Unverified

2,102 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 277 are open to participants now.

This study's enrollment of 319 is above the median of 239 across 367 observational studies indexed under Acquired Immunodeficiency Syndrome.

Browse Acquired Immunodeficiency Syndrome studies →

Lead sponsor

FHI 360 is the lead sponsor of 59 studies on the registry; none are open to participants now.

Compared within Acquired Immunodeficiency Syndrome, the registry's first condition term, which may not be this study's main condition. Counted across the registry records on this site, refreshed daily. How we classify →

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Females aged 18-49

Eligibility criteria

Inclusion Criteria:females aged 18-49 receiving health services at a field day event -

Exclusion Criteria:

-

05

Study design

Enrollment
319 participants (actual)
06

What researchers measure

Primary outcomes

  1. Health Services Research

    Unmet need for family planning among women attending Field Days aged 18-49

    Time frame: 1 year

Secondary outcomes

  1. Health Services Research

    Interest in receiving health services through Field Day model

    Time frame: 1 year

07

Study locations

1 site
  • 5 Community Outreach Events
    Various, Rift Valley & Central, Kenya
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 29, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01226433
Lead sponsor
FHI 360
Collaborators
United States Agency for International Development (USAID)
Responsible party
Sponsor
First posted
Oct 22, 2010
Start date
Oct 2010
Primary completion
Dec 2010
Completion
Dec 2010
Last update
Mar 29, 2013

Study contacts

John Bratt, MPP, MA
principal investigator · FHI 360

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion